The Training
Peptides for Recovery: Why Athletes Hear Big Promises and Find Small Evidence
Athletes seeking recovery peptides like BPC-157 often encounter promising animal studies but lack FDA approval and human evidence, while GLP-1 agonists, though FDA-approved for medical use, are not for athletic performance. Understanding the evidence, approval status, and sourcing is crucial to avoid health and anti-doping risks.
Yara Haddad·November 14, 2026